RESOLVING THE LEDGER
This is one outlet's own report from CBS News — Top — the article as it was filed. Other outlets are covering the same event; open the full story to compare every source side by side.
See the full story · 1 sources
Taking weight-loss drugs could help unemployed women get a job, according to new research.\u00a0Unemployed women taking\u00a0GLP-1 medications\u00a0to lose weight saw a 27 percentage-point increase in employment after 18 months of use, compared with women who want to use the drugs but haven\u0027t done so, Harvard economist Rebecca Diamond said in a recent paper published by the National Bureau of Economic Research.The data adds to an existing body of research documenting a so-called "obesity penalty" disproportionately affecting heavier women, who tend to earn less and who are less likely to marry or live with a partner. Women who started taking the drugs saw their marriage and cohabitation rates rise by 29 percentage points after 18 months of using a GLP-1 treatment, Diamond also found.\u00a0Although such findings suggest that\u00a0GLP-1 usage\u00a0can affect economic or social outcomes for women, there\u0027s no evidence that the drugs helped already employed women advance in their careers by earning a raise or promotion, noted Diamond, who didn\u0027t immediately respond to a request for comment.The research also raises questions about who can access GLP-1 drugs, given that early adopters tend to be "disproportionately financially advantaged," she wrote.\u00a0"If medical weight loss changes how women are treated in markets, then unequal access to the drugs may also shape who can avoid the social and economic penalties attached to body size," Diamond wrote. "It is also unsettling to think about using medical treatment as a possible remedy for discrimination."What is the "female obesity penalty"?Existing research\u00a0shows that obese women face discrimination in the labor market. They tend to earn less money and receive fewer callbacks\u00a0after first interviews than their lighter peers do.\u00a0GLP-1s can change that reality for heavier women, who are increasingly turning to the drugs expressly to slim down. By the end of 2024, 6% of women had started using a GLP-1 for the purpose of slimming down, according to Diamond, who notes that uptake is greater among women with a history of obesity, 9% of whom had turned to the drugs to lose weight.\u00a0Diamond used the Understanding America Study, a nationally representative survey of U.S. adults, to compare women who start a GLP-1 regimen to lose weight with their counterparts who have not yet begun a GLP-1 weight-loss regimen."Women not employed at baseline also move into work," she writes, noting that employment gains build gradually as job candidates become slimmer. Workers who were unemployed and found jobs accounted for most of the employment gains, rather than people who returned from retirement or disability.\u00a0What accounts for the change?\u00a0Prospects for employed women who start taking GLP-1s don\u0027t change because a first impression was formed a long time ago, and their subsequent career trajectories likely reflect other factors, such as performance, the study found.In other words, the "obesity penalty" is strongest during the interview process and less prevalent in workplaces.\u00a0Diamond posits that a decline in weight-related health issues could account for weight-loss drug users\u0027 improved prospects, but she found that employment gains in her study population exceed reported work limitations, and that candidates\u0027 visible weight loss accounts for most of the increase in employment.\u00a0
AIPROPX is an independent multi-source news index — we track, compare, and connect coverage from across the web into one place you won't find anywhere else.